prof. MUDr. Marek Svoboda, Ph.D.
Professor, Comprehensive Cancer Care Department
Office: pav. Švejdův
Žlutý kopec 534/7
656 53 Brno
Phone: | +420 543 134 102, +420 543 134 103 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 338
2015
-
Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma
International Journal of Molecular Sciences, year: 2015, volume: 16, edition: 10, DOI
-
Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
Diagnostic Pathology, year: 2015, volume: 10, edition: April, DOI
-
Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma
Carcinogenesis, year: 2015, volume: 36, edition: 5, DOI
-
Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency
European Journal of Cancer, year: 2015, volume: 51, edition: 4, DOI
-
Charakterizace exprese epiteliálních a mezenchymálních markerů zapojených do procesu EMT u pacientů s renálním karcinomem
Year: 2015, type: Conference abstract
-
Imunoterapie v prevenci a léčbě karcinomu prsu
Klinická onkologie, year: 2015, volume: 28, edition: 6
-
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
Oncotarget, year: 2015, volume: 6, edition: 36, DOI
-
miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
BioMed Research International, year: 2015, volume: 2015, edition: 941980, DOI
-
MiR-205 má vlastnosti nádorového supresoru u adenokarcinomu a onkogenu u dlaždicobuněčného karcinomu jícnu
Year: 2015, type: Conference abstract
-
MiR-215 is a tumor suppressor in colorectal cancer in vitro and in vivo
Year: 2015, type: Conference abstract